In United States almost 20 percent of deaths are due to heart diseases every year. Many researchers opine that this figure could possibly be reduced if the vulnerability of patients to heart disease is assessed at right time and with precision. The recent study of pathophysiology of heart disease is making a roadway on these lines of understanding and assessing vulnerabilities of patients to heart diseases.
Long back, medical professionals have found out that lipids present in blood can play a very decisive role in causing coronary heart disease and the latest pathophysiology of heart disease has now shown that among the lipids, decreasing the low-density lipoprotein levels in blood can actually aid in reducing the risks of coronary heart disease in persons.
Whenever the lipids present in blood is in excess, it will form as a plaque over the inner walls of arteries and treatment will be given to reduce this lipid levels either to slowdown the plaque formation or to stop formation of such plaque deposits.
Now the new pathophysiology of heart disease throws some more light on coronary heart disease and it says that a chronic inflammation due to injury or infection could trigger heart disease and it also establishes that in case of efforts to lower the amounts of low-density lipoprotein can in turn reduce the inflammation severity.
Many medical professionals have turned their attention towards pathophysiology of heart disease, which is nothing but a study of heart disease and its causes. Pathophysiology of heart disease is extensively and elaborately done in two centers namely University of Texas Health Science Center and The Cleveland Clinic, located in Cleveland, Ohio.
Further, it has also been found that inflammation can cause atherosclerosis and one more form of coronary heart disease namely hardening of arteries that lead to heart attacks.
Understand Signs to Understand Vulnerability
The pathophysiology of heart disease is useful in identifying patients who are vulnerable to blood thickening, a potentially major cause for fatal arrhythmia, and it is also used to screen patients who are vulnerable to other major coronary diseases.
It is the pathophysiology of heart disease that identified low-density lipoproteins with that of arterial sclerosis and the threat of myocardial degradation.
At the Cleveland Clinic, pathophysiology of heart disease in not only directed towards assessing the heart disease, but also done in order to find suitable and effective ways to prevent and to reverse the effects of coronary heart disease. The clinic is continuing to practice intervention therapy for heart patients as a part of its research programme.
The pathophysiology of heart disease is still in its infancy, and hence some more time will lapse in order to get a firm footing for identifying the various underlying factors of coronary heart disease. Till such time, the physicians will be continuing with the existing treatment methods of reducing the low-density lipoproteins levels, through medications and through advice for lifestyle change.
[tags]Atheroscelorosis, Lipoproteins[/tags]